Physiology of fas-induced programmed cell death

Cellular Physiology and Biochemistry

Volumn 6, Issue 6, 1996, Pages 361-375

  Gulbins, E ^a   Szabo, I ^a   Lang, F ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; CD95 Fas Apo 1; Signal transduction

Indexed keywords

CELL SURFACE RECEPTOR; CERAMIDE; FAS ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; PROTEIN TYROSINE KINASE; PROTEINASE; SPHINGOMYELIN;

APOPTOSIS; CELL PROLIFERATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030446492     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000154839     Document Type: Article

References (137)

1. Nagata S, Goldstein P: The Fas death factor. Science 1995:267: 1449.
2. Green DR. Scott DW: Activation-induced apoptosis in lymphocytes. CurrOpin Immunol 1994:6:476.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995:267:1456.
4. Baffy G. Miyashita T. Williamson JR. Reed JC: Apoptosis induced by withdrawal of IL-3 from an Independent hematopoietic cell line is associated with repartitioning of in-tracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 1993;268:6511.
5. Raff MC. Barres BA. Burne JF. Coles HS, Ishizaki Y. Jacobson MD: Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 1993: 262:695.
6. Lowe SW, Schmitt EM, Smith SW. Osborne BA. Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993:362:847.
7. Clarke AR, Purdic CA, Harrison DJ, Morris RG. Bird CC. Hooper ML. Wyllic AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849.
8. Smith CA. Williams GT. Kingston R. Jcnkinson EJ. Owen JJT: Antibodies to CD3/T cell receptor complex induce death in immature T cells in thymic cultures. Nature 1989:337:181.
9. Shi Y. Sahai BM. Green DR: Cyclosporin A inhibits activation-induced cell death in a T cell hvbrido-maand in thymocytes. Nature 1989; 339:625.
10. Owen-Schaub LB. Yonehara S. Crump WL. Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.Cell Immunol 1992:140:197.
11. Klas C. Debatin KM, Jonker RR. Krammcr PH: Activation interferes with the APO-I pathway in mature human Tcells. Int Immunol 1993:5: 625.
12. Mapara MY. Bargou R. Zugck C. Dohncr H. Ustaoglu F. Jonker RR. Krammer PH: APO-I mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with Bcl-2 oncogene expression. Eur J Immunol 1993:23: 702.
13. Hockenbery DM, Nunez G, Milli-man C. Schreiber RD. Korsmeycr SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334.
14. Nunez G. London L. Hockenbery D. Alexander M. McKcarn JP. Korsmeycr SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990:144:3602.
15. McDonnell TJ. Deane N. Platt FM. Nunez G. Jaeger U, McKeam JP. Korsmeycr SJ: Bcl-2-immunoglobu-lin transgenic mice demonstrate extended B cell survival and follicular lymphoprolifération. Cell 1989:57: 79.
16. Hockenbery DM. Oltavi ZN. Yin XM. Milliman CL. Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993:75:241.
17. Hengartncr MO. Horvitz HR: Activation of C. Clegans cell death protein CED-9 by an amino acid substitution in a domain conserved in Bcl-2. Nature 1994;369-318.
18. Hengartncr MO. Ellis RE. Horvitz HR: Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992:356: 494.
19. Hengartncr MO. Horvitz HR: C. Elegans survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994;76:655.
20. Boise LH. Gonzales-Garcia M. Pos-tema CE, Ding L, Lindstein T, Tur-ka LA, Mao X. Nunez G. Thompson CB: Bcl-x, a bcl-2-rclated gene that functions as a dominant regulator of apoptotic cell death. Cell 1993:74: 597.
21. Oltavi ZN, Milliman CL. Korsmeycr SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax. that accelerates programmed cell death. Cell 1993;74:609.
22. Kozopas KM. Yang T. Buchan HL. Zhou P. Craig RW: MCLI, a gene expressed in programmed myeloid cell differentiation has sequence similarity to Bcl-2. Proc Natl Acad Sci USA 1993:90:3516.
23. Lin EY. Orlofsky A. Bergar M. Prys-towsky MB: Characterization of AI. A novel hematopoietic-specific early response gene with sequence similarity to Bcl-2. J Immunol 1993:151 : 1979.
24. Korsmeyer SJ. Shutter JR. Veis DJ, Merry DE, Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993:4:327.
25. Gillardon F, Wickcrt H. Zimmermann M: Differential expression of bcl-2 and bax mRNA in axotomized dorsal root ganglia of young and adult rats. Eur J Ncurosci 1994:6: 1641.
26. Yang E, Zha J. Jockel J. Boise LH. Thompson CB. Korsmeyer SJ: Bad. A heterodimeric partner for BcI-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995:80:285.
27. Cohen PL. Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliférative disease. Ann Rev Immunol 1991;9:243.
28. Bhandoola A. Yui K. Siegel RM, Zcrva L, Greene MI: Gld and lpr mice: Single gene mutant models for failed self tolerance. Int Rev Immunol 1994; 11:231.
29. Watanabe-Fukunaga R. Brannan CL Itoh N, Yonehara S. Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992:148:1274.
30. Watanabe-Fukunaga R, Brannan CL Copeland NG. Jenkins NA. Nagata S: Lymphoprolifération disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992:356:314.
31. Adachi M. Watanabe-Fukunaga R. Nagala S; Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc Natl Acad Sci USA 1993:90: 1756.
32. Suda T. Takahashi T. Goldstein P. Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993:75:1169.
33. Rieux-Laucal F, Lc Deist F. Hivroz C. Roberts IAG. Debatin KM. Fischer A. de Villarty JP: Mutations in Fas associated with human lymphoproliférative syndrome and autoimmunity. Science 1995:268: 1347.
34. Bcrke G: The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Ann Rev Immunol 1994:12: 735.
35. Rao L, Debbas M. Sabbatini P. Hockenbery D. Korsmeyer S, White E: The adenovirus F.IA proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992: 89:9974.
36. Boyd JM. Malstrom S. Subraman-ian T. Venkatesh LK. Schacper U. Elangovan B. D’sa-Eipper C. Chin-nadurai G: Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994:79:341.
37. Neilan JG. Lu Z. Afonso CL. Kutish GF. Sussman MD. Rock DL: An African swine fever virus with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRFI.J Virol 1993,67:4391.
38. Henderson S. Hucn D. Rowe M. Dawson C. Johnson G. Rickinson A: Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bel-2, protects human B cells from programmed cell death. Proc Nail Acad Sci USA 1993:90:8479.
39. Ray CA. Black RA. Kronheim SR. Greenstreel TA. Sleath PR, Salves-en GS, Pickup DJ: Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the intcrleukin-1 beta converting enzyme. Cell 1992:69:597.
40. Gagliardini V. Fernandez PA. Lee RKK. Drexler HCA. Rotclio RJ. Fishman MC. Yuan J: Prevention of vertebrate neuronal death by the crniA gene. Science 1994:263:826.
41. Wang L. Miura M, Bergeron L. Zhu H. Yuan J: lch-1. And lce.ced-3-relalcd gene, encodes both positive and negative regulators of programmed cell death. Cell 1994:78:739.
42. Miura M. Zhu H. Rotclio R. Hart-wig EA. Yuan J: Induction of apoptosis in fibroblasts by 1L-1 beta-converting enzyme, a mammalian homolog of the C. Clegans cell death gene ccd-3. Cell 1993:75:653.
43. Boudreau N. Sympson CJ. Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995:267:891.
44. Enari M. Hug H, Nagala S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375:78.
45. Iavs M. Van de Craen M. Penning LC, Schenk H. Wcstendorp M, Baeuerle PA. Drôge W, Krammcr PH. Fiers W. Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/APO-1 -mediated apoptosis. Nature 1995:375:81.
46. Allen LP. Banerjee S. Franklin S. Herzog L. Johnson C. McDowell J. Paskind M. Rodman L, Salfield J: Mice deficient in IL-1 beta converting enzyme are defective in production of mature 1L-I beta and resistant to septic shock. Cell 1995:80: 401.
47. Debatin KM. Fahrig-Faissner A. Enenkel-Stoodt S. Kreuz W. Benner A. Krammcr PH: High expression of APO-I (CD95) on T lymphocytes from human immunodeficiency vi-rus-1-infected children. Blood 1994: 83:3101.
48. Kobayashi N. Hamamoto Y, Yamamoto N. Ishii A. Yonchara M. Yone-hara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990; 87:9620.
49. Oyaizu N. McCloskcv TW. Corone-si M. Chirmule N. Kalyanaraman VS. Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993:82:3392.
50. Oyaizu N. McCloskcv TW. Than S. Hu R. Kalyanaraman VS. Pahwa S: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 1994:84: 2622.
51. Hiromatsu K. Aoki Y, Makino M. Matsumoto Y. Mizuochi T. Gotoh Y. Nomoto K, Ogasawara J. Nagata S. Yoshikai Y: Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur J Immunol 1994:24:2446.
52. Itoh N. Yonchara S. Ishii A. Yone-hara M. Mizushima S. Sameshima M. Hase A, Seto Y. Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991: 66:233.
53. Watanabe-Fukunaga R. Brannan CL Itoh N. Yonchara S. Copeland NG. Jenkins NA. Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992:148:1274.
54. Cosman D: A family of ligands for TNF receptor superfamily. Stem Cells 1994:12:440.
55. Tartaglia LA. Ayres TM. Wong GHW. Goeddel DV; A novel domain w ithin the 55 kd TNF receptor signals cell death. Cell 1993:74:845.
56. Rothe M. Wong SC. llenzcl WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994;78:681.
57. Chinnaiyan AM. O'Rourke K. Tc-wari M. Dixit VM: FADD. A novel death domain-containing protein interacts with the death domain of Fas and indicates apoptosis. Cell 1995; 81:505.
58. Stangcr BZ. Lcdcr P. Lee TH. Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/Apol (CD95) in yeast and causes cell death. Cell 1995:81: 513.
59. Boldin MP, Goncharov TM. Golt-sev YV, Wallach D: Involvement of MACH, a novel MORTI/FADD-in-teracting protease, in Fas/Apo-1-and TNF receptor induced cell death. Cell 1996:85:803.
60. Muzio M. Chinnaiyan AM. Kisch-kel FC. O'Rourke K, Shevchenko A. Ni J, Scalfidi C. Bretz JD. Zhang M. Gentz R. Mann M. Krammer PH. Peter ME, Dixit VM: FLICE. A novel FADD homologoud ICE/CED-3 like-protease, is recruited to the CD95/(Fas/Apo-I) death inducing signaling complex. Cell 1996:85: 817.
61. Sato T. Irie S. Kitada S. Reed JC: FAP-I: A protein tyrosine phosphatase that associates with Fas. Science 1995:268:411.
62. Ogasawara J. Suda T. Nagata S: Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 1995; 181:485.
63. Debatin KM. Siiss D. Kxammcr PH: Differential expression of APO-I on human thymocytes: Implications of negative selection? Eur J Immunol 1994:24:753.
64. Kotzin BL, Babcock SK. Herron LR: Deletion of potentially self-reactive T cell receptor specificities in L3T4-. Lyt-2-T cells of Ipr mice. J Exp Med 1988:168:2221.
65. Singer PA, Balderas RS. McEvilly RJ. Bobardt M. Theofilopoulos AN: Tolerance-related V beta clonal deletions in normal CD4-8-TCR-al-pha/beta+ and abnormal Ipr and gld cell populations. J Exp Med 1989: 70:1869.
66. Giese T. Davidson WF: Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for Ipr. J Immunol 1992:149: 3097.
67. Zhou T, Bluethmann II. Zhang J. Edwards C 3rd, Mountz JD: Defective maintenance of T cell tolerance to a superantigen in MRL-Ipr/lpr mice. J Exp Med 1992:176:1063.
68. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic nice. Immunity 1994:1:365.
69. Zhou T. Bluethmann H. Eldridge J. Brockhaus M. Berry K. Mountz JD: Abnormal thymocyte development and production of autorcactive T cells in T cell receptor transgenic autoimmune mice. J Immunol 1991; 147:466.
70. Falk MH. Trauth BC, Debatin KM. Klas C. Gregory CD. Rickinson AB. Calender A. Lenoir GM. Ellwart JW. Krammer PH. Et al: Expression oflhe APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 1992:79:3300.
71. Trauth BC. Klas C, Peters AM. Matzku S. Moller P. Falk W. Deban-tin KM. Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989:245:301.
72. Dhein J. Walczak H. Baumlcr C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-l/(Fas/CD95). Nature 1995: 373:438.
73. Brunner T. Mogil RJ. LaFace D. Yoo NJ. Mahboubi A. Echeverri F. Martin SJ. Force WR, Lynch DH, Ware CF. Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995:373:441.
74. Ju ST. Panka DJ. Cui H. Ettingcr R. El-Khatib M. Sherr DH. Stanger BZ. Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995:373: 444.
75. Ju ST. Cui H. Panka DJ. Ettingcr R. Marshak-Rothstein A: Participation of target Fas protein in apoptosis pathway induced by CD4+ Till and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 1994:91:4185.
76. Stalder T. Hahn S. Erb P: Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994:152:1127.
77. Hanabuchi S. Koyanagi M. Kawasaki A, Shinohara N, Matsuzawa A. Nishimura Y. Kobayashi Y. Yone-hara S. Yagita H. Okumura K: Fas and its ligand in a general mechanism of T-cell-mcdiated cytotoxicity. Proc Natl Acad Sci USA 1994; 91:4930.
78. Jones LA. Chin LT. Longo DL, Kruisbeek AM: Peripheral clonal elimination of functional T cells. Science 1990;250:1726.
79. Kawabc Y. Ochi A: Programmed cell death and extrathymic reduction of Vß8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991:349: 245.
80. Gonzalo JA. Alboran IM. Ales-Mar-tinez JE. Martinez AC. Krocmer G: Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interlcukin-2 pathway. Eur J Immunol 1992:22:1007.
81. Russell JH. Rush B. Weaver C. Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993:90:4409.
82. Cifonc MG. De Maria R. Roncaioli P. Rippo MR. Azuma M, Lanier LL. Santoni A. Testi R: Apoptotic signaling through CD95 (Fas/Apo-I) activates an acidic sphingomyelinase. J Exp Med 1994:180:1547.
83. Gulbins E, Bissonnettc R. Mahbou-bi A. Martin S. Nishioka W. Brunner T. Baier G. Baier-Bittcrlich G. Byrd C, Lang F, Kolesnick R. Altman A. Green D: FAS-induced apoptosis is mediated via a ceram-ide-initiated RAS signaling pathway. Immunity 1995:2:341.
84. Jarvis WD. Kolesnick RN. Fornari FA. Traylor RS. Gcwirtz DA. Grant S: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994:91:73.
85. Obeid LN. Linardic CM. Karolak LA. Hannun YA: Programmed cell death induced by ccramidc. Science 1993:259:1769.
86. Spence MW: Sphingomyelinases. Adv Lipid Res 1993:26:3.
87. Chatterjee S: Neutral sphingomyelinase. Adv Lipid Res 1993:26:25.
88. Spence MW. Callahan JW: Sphingomyelin-cholesterol lipidoses: The Niemann-Pick group of diseases: in: The Metabolism Basis of Inherited Disease, ed 6. New York. McGraw-Hill. 1989.
89. Gulbins E. Coggeshall KM. Brenner B. Schlottmann K. Lindcrkamp O. Lanf F: Fas-induccd apoptosis is mediated by activation of a Ras and Rac protein regulated signaling pathway. J Biol Chem 1996:in press.
90. Gulbins E, Brenner B. Hermisson M. Koppenhoefer U. Linderkamp O. Coggeshall KM. Lang F: Ras induces apoptosis by Ras regulated phosphoinosit ide-3-kinase activation. Mol Cell Biol 1996;submitted.
91. Latinis KM. Koretzky GA: Fas-Iiga-tion induces apoptosis and Jun activation independently of CD45 and Lck in human T-cells. Blood 1996: 87:871.
92. Minden A. Lin A. Claret FX, Abo A. Karin M: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995:81:1147.
93. Vcrheij M. Bose R. Lin XII. Yao B. Jarvis WD. Grant S. Birre MJ. Szabo E. Zon LI, Kyriakis JM. Haimo-vitz-Fricdman A. Fuks Z. Kolesnick RN: Requirement for ceramidc initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996:380:75.
94. Joseph CK. Byun HS. Bittman R. Kolesnick RN: Substrate recognition by ceramide-activatcd protein kinase. J Biol Chem 1993:268: 20002.
95. Raines MA. Kolesnick RN, Golde DW: Sphingomyelinase and ceramidc activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993:268:14572.
96. Dobrowsky RT. Hannun YA: Cer-amidc stimulates a cytosolic protein phosphatase. J Biol Chem 1992:267: 5048.
97. Gulbins E, Coggeshall KM. Baier G. Telford D, Langlct C. Baier-Bilter-lich G. Bonnefoy-Berard N. Bum P, Wittinghofcr A, Allman A: Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglyccridcs. Mol Cell Biol 1994:14:4749.
98. Machleidt T. Wiegmann K. Henkel T, Schütze S, Baeucrlc P. Krdnkc M: Sphingomyelinase activates proteolytic licB-degradation in a cell-free system. J Biol Chem 1994:269:13760.
99. Eischen CM. Dick CJ. Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994:153:1947.
100. Schlottmann K. Gulbins E, Lau SM. Coggeshall KM: Activation of sre family kinases during Fas induced apoptosis. J I.eukocyt Biol 1996:in press.
101. Szabo I. Gulbins E. Apfel H, Zhang X. Barth P. Busch AE, Schlottmann K. Pongs O, Lang F: Tyrosine phosphorylai ion-depen-dent suppression of a voltage-gated K* channel in T lymphocytes upon Fas stimulation. J Biol Chem 1996:271:20465.
102. Leonard RJ. Garcia ML. Slaughter RS. Reuben JP: Selective blockers of voltage gated K* channels depolarize human T lymphocytes: Mechanism of the antiproliferative effect of charybdotoxh. Proe Natl Acad Sci USA 1992:89: 10094.
103. Lin CS, Boltz RC. Blake JT. Nguyen M. Talento A. Fischer PA. Springer MS. Sigal NIL Slaughter RS, Garcia ML. Kaczorowski GJ. Koo GC: Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocytes activation. J Exp Med 1993:177:637.
104. Freedman BD, Price MA, Deutsch CJ: Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes. J Immunol 1992:149:3784.
105. Broome HE. Dargan CM. Bcssent EF. Krajewski S. Reed JC: Apoptosis and BcI-2 expression in cultured murine splenic T cells. Imm-munology 1995:84:375.
106. 24 level. J Immunol 1995:154:599.
107. Ruiz Ruiz MC. Oliver FJ. Izquierdo M, Lopez Rivas A: Activation-induced apoptosis in Jurkat cells through a myc-indepcndent mechanism. Mol Immunol 1995:32: 947.
108. Deckers CL, Lyons AB. Samuel K. Sanderson A. Maddy AH: Alternative pathways of apoptosis induced by méthylprednisolone and valino-mycin analyzed by flow cytometry. Exp Cell Res 1993:208:362.
109. Grinstcin S. Smith JD: Calcium-independent cell volume regulation in human lymphocytes: Inhibition by charybdotoxin. J Gen Physiol 1990:95:97.
110. 4channels in T lymphocytes: Functional consequences for volume regulation. Proc Natl Acad Sci USA 1993:90:10036.
111. Enokido Y. Hatanaka H: Apoptotic cell death occurs in hippocampal neurons cultured in a high oxygen atmosphere. Neuroscience 1993: 57:965.
112. 24 influx but not Trk activation. J Neurosci 1995:15: 643.
113. 24 induced regulation of ion channel and MAP kinase functions. Nature 1995:376:737.
114. Hockcnbery DM. Oltvai ZN, Yin XM. Milliman CL. Korsmeyer SJ: Bcl2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993:75:241.
115. Buttke IM. Sandstrom PA: Redox regulation of programmed cell death in lymphocytes. Immunol Today 1994:15:7.
116. Um HD. Orcnstein JM. Wal SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 1996:156:3469.
117. Ramakrishnan N, Catravas G: N-(2 -mcrcapthoethyl) -1.3 - propane -diamine (WR-1065) protects thymocytes from programmed cell death. J Immunol 1992:148:1817.
118. Mayer M. Noble M: N-acctyl-z-cysteinc is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994:91:7496.
119. Matsuda M. Masutani H. Nakamura H. Miyajima S. Yamaguchi A. Yonehara S. Uchida A. Irima-jiri K. Horiuchi A, Yodoi J: Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor. J Immunol 1991:147:3837.
120. Kane DJ. Sarafian TA. Anton R, Hahn H, Butler Gralla E. Sclver-stone VJ. Ôrd T. Brcdesen DE: Bcl2-inhibition of neural death decreased generation of reactive oxygen species. Science 1993:262: 1274.
121. Hirosc K. Bongo DL, Oppenheim JJ. Matsushima K: Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anlicancer drugs, and ionizing radiation. FASEB J 1993; 7:361.
122. Iloh N. Tsujimoto Y. Nagata S: Effect of Bcl-2 on Fas antigen mediated cell death. J Immunol 1993: 151:621.
123. Takayama S. Sato T. Krajcwski S. Kochcl K. Irie S. Millan JA. Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 1995:80:279.
124. Chiba T, Takahashi S. Sato N, lshii S. Kikuchi K: Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur J Immunol 1996:26:1164.
125. Jacobson MD. Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 1995:374:814.
126. Boguski MS, McCormick F: Proteins regulating Ras and its relatives. Nature 1993:366:643.
127. Hall A: The cellular functions of small GTP-binding proteins. Science 1990:249:635.
128. Vojtck AB, Cooper JA: Rho Family members: Activators of MAP kinase cascades. Cell 1995:82:527.
129. Evan GI. Wyllie AH, Gilbert CS, Littlewood TD, Land H. Brooks M, Waters CM. Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119.
130. Shi Y. Glynn JM. Guilbert U, Cotter TG. Bissonette RP. Green DR: Role for c-myc in activation-induced apoptotic cell death in T-ccll hybridomas. Science 1992; 257:212.
131. Colotta F. Polentarutti N, Sironi M. Mantovam A: Expression and involvement ofc-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992:267:18278.
132. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg A: Premature p34cdc2 activation required for apoptosis. Science 1994;263:1143.
133. Wyllie A, Rose KA, Morris RG, Steel CM. Foster E, Spandidos DA: Rodent fibroblast tumoursexpressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression. Br J Cancer 1987:56:251.
134. Tanaka N, Ishihara M. Kitagawa M. Harada H. Kirnura T. Matsuyama T. Lamphier MS, Mak TW. Taniguchi T: Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994;77:829.
135. Wang HG. Millan JA. Cox AD. Dcr CJ. Rapp UR. Beck T. Zha H. Reed JC: R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol 1995:129: 1103.
136. Henkemcycr M. Rossi DJ. Hol-ntyard DP. Puri MC. Mbamaula G. Harpal K. Shih TS. Jacks T. Pawson T: Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature 1995:377:695.
137. Lau HT. Yu M. Fontana A, Stoeckert CJ: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996:273:109.